Effects of clopidogrel on mortality, cardiovascular and bleeding outcomes in patients with chronic kidney disease - data from Taiwan acute coronary syndrome full spectrum registry.
BACKGROUND: The efficacy of clopidogrel is inconclusive in the chronic kidney disease (CKD) population with acute coronary syndrome (ACS). Furthermore, CKD patients are prone to bleeding with antiplatelet therapy. We investigated the efficacy and safety of clopidogrel in patients with ACS and CKD. M...
Main Authors: | Tsung-Hsien Lin, Wen-Ter Lai, Ho-Tsung Hsin, Ai-Hsien Li, Chun-Li Wang, Chi-Tai Kuo, Juey-Jen Hwang, Fu-Tien Chiang, Shu-Chen Chang, ACS Full Spectrum Registry Investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3756021?pdf=render |
Similar Items
-
Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry
by: Fu-Tien Chiang, et al.
Published: (2014-11-01) -
Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel
by: Gwang-Un Kim, et al.
Published: (2021-01-01) -
Puncture site bleeding complications in patients with Clopidogrel hyper-response
by: Nedeljković Žarko, et al.
Published: (2020-03-01) -
Thoracentesis under clopidogrel is not associated with excessive bleeding events: a cohort study
by: Sivan Perl, et al.
Published: (2020-10-01) -
Postoperative Bleeding Risk for Oral Surgery under Continued Clopidogrel Antiplatelet Therapy
by: Alexander Gröbe, et al.
Published: (2015-01-01)